Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002419559 | SCV002720358 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-08-19 | criteria provided, single submitter | clinical testing | The p.R67S variant (also known as c.201G>T), located in coding exon 2 of the BRCA2 gene, results from a G to T substitution at nucleotide position 201. The arginine at codon 67 is replaced by serine, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |